NCT05465759|Unknown
Frequency of SARS COVID-19 Infection Among Malignant Patients at South Egypt Cancer Institute
Frequency of SARS COV-2 Infection Among Malignant Patients at South Egypt Cancer Institute
Loading search results
Frequency of SARS COV-2 Infection Among Malignant Patients at South Egypt Cancer Institute
Sponsor study identifier
observational
200
0 countries
N/A
Study Start
July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
July 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Assessment the frequency of SARS COV-2 infection among malignant patients at south Egypt Cancer institute
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
August 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
July 13, 2022
Actual (reported)July 20, 2022
Actual (reported)July 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
August 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
calculate the frequency of SARS-CoV-2 infection among patients with malignant data collection during the study period
To calculate the rate of SARS-CoV-2 infection among patients with malignant data collection within covid-19 pandemic either retrospective or prospective. Data will include : patient demography such as Age,sex,smoking status,cancer type cancer treatment (patient on chemotherapy or radiotherapy if available), symptoms, signs and laboratory parameters of COVID -19. outcome including hospitalization or ICU admission and mortality rate will be recorded
1 year
Frequency of SARS COV-2 infection among malignant patients at south Egypt Cancer institute.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
patients at south Egypt cancer institute
First Submitted
July 13, 2022
First Posted
July 20, 2022
Study Start
July 2022
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Primary Completion
July 2023
A Study on Children With COVID-19 Admitted at Assiut University Children Hospital
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
August 2023
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
July 20, 2022
Record last verified: 2022-07
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: